SGS Pharma Clinical Research is a leading CRO specializing in early-stage development and functional biometrics (Phases I–IV). With a strong presence in Europe and the Americas, SGS offers a comprehensive range of clinical trial services, including full early-phase drug development consultancy, clinical project management and monitoring, biometrics, as well as medical safety and regulatory services. SGS has its own clinical unit with a total of 110 hospitalization beds in Belgium, including a separate quarantine unit with 45 beds for CHIM studies, and has a wealth of expertise in FIH studies, human viral challenge testing, biosimilars and complex PK/PD studies with a strong therapeutic focus on Infectious Diseases, Vaccines, Respiratory, Dermatology and Oncology.